PBS Biotech, a Camarillo, CA-based single-use bioreactor manufacturer, closed a $10M funding round.
BroadOak Capital Partners made the investment.
The company intends to use the funds to expand and industrialize its portfolio of single-use bioreactor systems and contract process development services.
Led by Brian Lee, CEO, PBS Biotech is a manufacturer of single-use bioreactor systems. The company utilizes proprietary Vertical-WheelTM technology to achieve unique mixing properties and environmental conditions for cell therapy products. In addition, the company operates an in-house bioprocess R&D facility to offer process expertise and development services to assist cell therapy customers in scaling up from research phases to clinical and commercial phases.
PBS Biotech systems are used by over 200 customers ranging from small-scale research and development groups to large-scale manufacturing groups. The company will look to secure and expand its product line over the next several years to support existing and future customers through clinical trials to commercialization.
FinSMEs
16/08/2021